{"id":13,"date":"2018-04-01T20:08:35","date_gmt":"2018-04-01T19:08:35","guid":{"rendered":"https:\/\/admin.innaxon.com\/?page_id=13"},"modified":"2025-08-20T11:58:40","modified_gmt":"2025-08-20T10:58:40","slug":"business-development","status":"publish","type":"page","link":"https:\/\/admin.innaxon.com\/index.php\/business-development\/","title":{"rendered":"Business Development"},"content":{"rendered":"\n<h2>\n\t\t\tInnaxon Therapeutics seeks to grow through collaborations, partnerships and new ventures.\t<\/h2>\n\t<p>Where appropriate, we pursue key technology and product licensing\/acquisition strategies to\u00a0build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key\u00a0of the innate immune system -Toll-like Receptor 4- to serve serious, unmet medical needs.<\/p>\n\t\t\t\t<img decoding=\"async\" src=\"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg\" alt=\"SCHOOL BAGPACK low poly gray\" itemprop=\"image\" height=\"750\" width=\"1500\" title=\"SCHOOL BAGPACK low poly gray\" onerror=\"this.style.display='none'\" loading=\"lazy\" \/>\n<h2>\n\t\t\tProduct\/technology development opportunities\u00a0that are of interest to Innaxon fall into the following commercial areas:\t<\/h2>\n\t<ul>\n<li>Therapeutic Vaccines and Adjuvants<\/li>\n<li>Infectious Diseases<\/li>\n<li>Immunotherapy of Cancer<\/li>\n<li>Anti-inflammatories<\/li>\n<\/ul>\n<h2>\n\t\t\tIf you have any questions about Innaxon Business Development activities,\u00a0please contact info@innaxon.com\t<\/h2>\n\n","protected":false},"excerpt":{"rendered":"<p>Innaxon Therapeutics seeks to grow through collaborations, partnerships and new ventures. Where appropriate, we pursue key technology and product licensing\/acquisition strategies to\u00a0build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key\u00a0of the<\/p>\n<p><a class=\"more-link\" href=\"https:\/\/admin.innaxon.com\/index.php\/business-development\/\">Read More<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-13","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Business Development - Innaxon Therapeutics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/admin.innaxon.com\/index.php\/business-development\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Business Development - Innaxon Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Innaxon Therapeutics seeks to grow through collaborations, partnerships and new ventures. Where appropriate, we pursue key technology and product licensing\/acquisition strategies to\u00a0build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key\u00a0of theRead More\" \/>\n<meta property=\"og:url\" content=\"https:\/\/admin.innaxon.com\/index.php\/business-development\/\" \/>\n<meta property=\"og:site_name\" content=\"Innaxon Therapeutics\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-20T10:58:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/admin.innaxon.com\/index.php\/business-development\/\",\"url\":\"https:\/\/admin.innaxon.com\/index.php\/business-development\/\",\"name\":\"Business Development - Innaxon Therapeutics\",\"isPartOf\":{\"@id\":\"https:\/\/admin.innaxon.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/admin.innaxon.com\/index.php\/business-development\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/admin.innaxon.com\/index.php\/business-development\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg\",\"datePublished\":\"2018-04-01T19:08:35+00:00\",\"dateModified\":\"2025-08-20T10:58:40+00:00\",\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/admin.innaxon.com\/index.php\/business-development\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/admin.innaxon.com\/index.php\/business-development\/#primaryimage\",\"url\":\"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg\",\"contentUrl\":\"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg\",\"width\":1500,\"height\":750},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/admin.innaxon.com\/#website\",\"url\":\"https:\/\/admin.innaxon.com\/\",\"name\":\"Innaxon Therapeutics\",\"description\":\"Targeting Innate Immunity For Therapeutic Benefit\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/admin.innaxon.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Business Development - Innaxon Therapeutics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/admin.innaxon.com\/index.php\/business-development\/","og_locale":"en_GB","og_type":"article","og_title":"Business Development - Innaxon Therapeutics","og_description":"Innaxon Therapeutics seeks to grow through collaborations, partnerships and new ventures. Where appropriate, we pursue key technology and product licensing\/acquisition strategies to\u00a0build our future value. By implementing this strategy, we will continue in its quest to become a leading provider of smart (bio-)pharmaceutical products, which modulate the master key\u00a0of theRead More","og_url":"https:\/\/admin.innaxon.com\/index.php\/business-development\/","og_site_name":"Innaxon Therapeutics","article_modified_time":"2025-08-20T10:58:40+00:00","og_image":[{"url":"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/admin.innaxon.com\/index.php\/business-development\/","url":"https:\/\/admin.innaxon.com\/index.php\/business-development\/","name":"Business Development - Innaxon Therapeutics","isPartOf":{"@id":"https:\/\/admin.innaxon.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/admin.innaxon.com\/index.php\/business-development\/#primaryimage"},"image":{"@id":"https:\/\/admin.innaxon.com\/index.php\/business-development\/#primaryimage"},"thumbnailUrl":"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg","datePublished":"2018-04-01T19:08:35+00:00","dateModified":"2025-08-20T10:58:40+00:00","inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/admin.innaxon.com\/index.php\/business-development\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/admin.innaxon.com\/index.php\/business-development\/#primaryimage","url":"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg","contentUrl":"https:\/\/admin.innaxon.com\/wp-content\/uploads\/2018\/04\/Innaxon-4-2.jpg","width":1500,"height":750},{"@type":"WebSite","@id":"https:\/\/admin.innaxon.com\/#website","url":"https:\/\/admin.innaxon.com\/","name":"Innaxon Therapeutics","description":"Targeting Innate Immunity For Therapeutic Benefit","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/admin.innaxon.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages\/13","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/comments?post=13"}],"version-history":[{"count":20,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages\/13\/revisions"}],"predecessor-version":[{"id":966,"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/pages\/13\/revisions\/966"}],"wp:attachment":[{"href":"https:\/\/admin.innaxon.com\/index.php\/wp-json\/wp\/v2\/media?parent=13"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}